[Federal Register Volume 68, Number 163 (Friday, August 22, 2003)]
[Notices]
[Page 50775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-21476]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the President's Council on Bioethics on 
September 4-5, 2003

AGENCY: The President's Council on Bioethics, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The President's Council on Bioethics will hold its thirteenth 
meeting, at which, among other things, it will hear and discuss 
presentations on the ethics and implementation of embryonic stem cell 
research funding, including testimony by Elias Zerhouni, MD, director, 
U.S. National Institutes of Health (NIH), Mark B. McClellan, MD, 
commissioner, U.S. Food and Drug Administration (FDA), and several 
interested parties from the private sector. The Council will also 
continue discussion of its ``beyond therapy'' and ``biotechnology and 
public policy'' projects. Subjects discussed at past Council meetings 
(and potentially touched on at this meeting) include: human cloning, 
embryo research, lifespan-extension research, organ procurement for 
transplantation, and extra-therapeutic powers to enhance or improve 
human mood, memory, or muscles. The Council may also discuss issues 
surrounding the regulation of assisted reproduction and reproductive 
genetics (including IVF, ICSI, PGD; sex selection, inheritable genetic 
modification; and the patentability of human genes, tissues, and 
organisms).

DATES: The meeting will take place Thursday, September 4, 2003, from 9 
a.m. to 5:15 pm ET; and Friday, September 5, 2003, from 8:30 am to 
12:30 pm ET.

ADDRESSES: Hotel Wyndham Washington DC, 1400 M Street NW., Washington, 
DC 20005.
    Public Comments: The meeting agenda will be posted at http://www.bioethics.gov. Members of the public may comment, either in person 
or in writing. A period of time will be set aside during the meeting to 
receive comments from the public, beginning at 11:30 am, on Friday, 
September 5. Comments will be limited to no more than five minutes per 
speaker or organization. Please inform Ms. Diane Gianelli, Director of 
Communications, in advance of your intention to make a public 
statement, and please give her your name, affiliation, and a brief 
description of the topic or nature of your comments. To submit a 
written statement, mail or e-mail it to Ms. Gianelli at one of the 
addresses given below.

FOR FURTHER INFORMATION CONTACT: Ms. Diane Gianelli, Director of 
Communications, The President's Council on Bioethics, Suite 700, 1801 
Pennsylvania Avenue, Washington, DC 20006. Telephone: 202/296-4669. e-
mail: [email protected]. Web site: http://www.bioethics.gov.

    Dated: August 11, 2003.
Dean Clancy,
Executive Director, The President's Council on Bioethics.
[FR Doc. 03-21476 Filed 8-21-03; 8:45 am]
BILLING CODE 4161-90-P